BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

AEROVANCE, INC

Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing biotherapeutics. The company maintains a solid intellectual property position with its strong portfolio of potential breakthrough products now in clinical development and several pre-clinical programs. The lead products are human recombinant proteins: AEROVANT™, an IL-4 and IL-13 receptor antagonist currently in Phase 2a studies for asthma; AEROLYTIC™, a serine protease inhibitor in Phase 2a for Cystic Fibrosis; AERODERM™, an IL-4 and IL-13 receptor antagonist in Phase 2a for eczema, and PULMOLYTIC™, a serine protease inhibitor in Phase 2a for COPD.

Aerovance was spun off from Bayer Healthcare's biotechnology unit in August 2004 and has a proven executive team, experienced in the field of respiratory disease and biologics drug development. The company’s venture capital investors are Alta Partners, APAX Partners, Burrill & Company, Clarus Ventures, Lehman Brothers and NGN Capital.


Contact Details:
2929 7th StreetSuite 130
Berkeley
California
94710
United States of America
Tel:510-549-5500
Fax:510-549-5501
Email:info@aerovance.com
WWW:

www.aerovance.com/




Loading...

BioNews Results for AEROVANCE, INC:

Interleukin-9 antagonist muteins and their pharmacological methods of use
PharmCast:  Sep 24 2008 4:08AM Matching: aerovance inc

AEROVANCE, INC Patents:

US Patent No.Title
7423123 Interleukin-9 antagonist muteins and their pharmacological methods of use
7404957 Modified IL-4 mutein receptor antagonists

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 290 times since April 2007, the link to the organisation's website has been followed 44 times

Recent Search Terms used to find this page: t | aerovance | pulmolytic | Aerovance- Business Development | Aerovance Inc Berkeley | aerolytic phase 2a | AEROVANCE inc | Pulmolytic for COPD | .

Search for more companies in Berkeley

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AEROVANCE, INC
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.